Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Active pharmaceutical ingredient (API) comprising cannabinoids for use in the treatment of cancer

Active pharmaceutical ingredient (API) comprising cannabinoids for use in the treatment of cancer

US Patent 9962341 · Granted May 8, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV2024
7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in th2023
Use of cannabinoids in the treatment of epilepsy2023
Use of cannabinoids in the treatment of inflammatory skin diseases2022
Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV2022
7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in th2021
Use of cannabinoids in the treatment of epilepsy2021
Use of cannabinoids in the treatment of multiple myeloma2021
Use of tetrahydrocannabinol and/or cannabidiol for increasing radiosensitivity i2020
Use of tetrahydrocannabinol and/or cannabidiol for increasing radiosensitivity i2020
Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV2020
Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors2019